M and G Share Price: Live MNG.L Quote & Forecast

M&G plc’s share price has drifted to 300.6p following its latest annual results, yet the London-listed insurer and asset manager continues delivering a dividend yield comfortably above 7% — a combination that raises questions income investors cannot afford to ignore.

Sell Price: 300.70p · Buy Price: 300.90p · Market Cap: £7.17bn · Shares Outstanding: 2.38bn · Ticker: MNG.L

Key financial metrics for M&G plc as of early 2026, sourced from multiple market data providers.

Is M&G a good share to buy?

The short answer depends entirely on what you own a stake for. M&G plc (Hargreaves Lansdown) presents a split personality: rock-solid capital strength sitting alongside persistent profitability challenges that keep the market cautious.

Current valuation metrics

At 300.6p, M&G trades at a forward P/E of 9.31 — a discount to the broader financial sector that analysts have noted reflects ongoing skepticism about the sustainability of its underwriting results, not just its asset-gathering momentum. The price-to-book ratio of 1.84 suggests the market is applying a meaningful haircut to the balance sheet despite assets under management and administration (AUMA) of £376bn at year-end FY2025 (M&G plc FY2025 Results). EV/EBITDA of 5.39 and EV/FCF of 5.65 position M&G as cheaper on an enterprise-value basis than many pure-play asset managers, though that discount has a reason: the life insurance arm adds complexity and model risk that pure fund houses do not carry.

“Group adjusted operating profit of £838m highlights the resilience and balance of our business model.”

— M&G Leadership, FY2025 Results Presentation

Analyst consensus

With a P/E of 23.58 versus a forward multiple around 9.3, the market appears to be applying a near-term discount while pricing in potential normalisation further out. The forward P/E discrepancy stems from the TTM loss position (-£0.02 EPS) that temporarily inflates the trailing multiple. Dividend yield benchmarks from Simply Wall St put M&G’s 7.8% yield in the top quartile of UK market yields — well above the UK’s bottom-quartile threshold of 2.1% and surpassing even the top quartile cut-off of 5.4%.

“Despite strong operational metrics, the stock’s decline suggests investors remain cautious about the sustainability of certain business segments.”

— Investing.com Analyst, Investing.com

Risk factors

Negative ROE of -1.23% TTM is a red flag that requires context: this reflects one-off items and legacy insurance reserve adjustments, not operational collapse. However, a payout ratio that turned negative at -133% in some analyses raises legitimate questions about whether the dividend is truly funded by operating cash flow or partially supported by capital recycling. Operating margin of 18.86% versus a negative net profit margin signals that below-the-line charges continue to drag reported earnings. Investors chasing the yield need to ask whether the current 20.5p annual payout is genuinely covered.

For UK income investors, the trade-off is concrete: M&G offers a dividend that few FTSE 350 peers can match, but the share price has little momentum and the business transformation is still in progress. The implication: a buy-and-hold income thesis can hold, but a capital-gains thesis requires patience and tolerance for near-term volatility.

What is the M&G share price forecast and target?

No analyst has formally published a consensus 12-month price target in the research reviewed, but the 52-week range of £1.96 to £3.25, with the current price near the lower end, tells its own story (PortfoliosLab). The YTD move of +6.7% into early 2026 shows the share has stabilised, but not recovered.

Short-term predictions

Short-term share price direction will hinge on two catalysts: whether M&G can sustain its net inflows in the first half of FY2026, and whether the annual report — published with the dividend raised to 20.5p — convinces institutional holders to add rather than trim. The post-results dip to 300.6p on 12 March 2026 (Investing.com) reflects caution, not disaster — the underlying inflows were strong, but the market has been conditioned to distrust life insurer earnings quality.

Historical performance

Looking back, M&G has traded in a band between roughly 195p and 325p over the past year, with the 300p level serving as a recurring support and resistance zone. The company returned to after-tax profit of £314m in FY2025 after a £347m loss the prior year (M&G plc FY2025 Results), which is the kind of swing that can shift sentiment quickly if the next annual cycle delivers another profit. Five-year cumulative inflows into public equities of £12bn demonstrate that the asset management franchise has genuine momentum, not just marketing spin.

Price targets from analysts

With no publicly available consensus target in the dataset, investors should treat any third-party price projections with scepticism. The absence of a clear Wall Street broker consensus makes M&G a stock where fundamental thesis — not sell-side target-setting — should drive the investment decision. What is clear from the financials is that any re-rating would likely require either a sustained inflow trend that pushes AUMA past £400bn, or a structural improvement in the life insurance result that removes the persistent earnings uncertainty discount.

How much is the next M&G dividend?

M&G pays dividends twice yearly — a pattern that makes the stock attractive for investors who want regular income flows rather than a single annual payment. The FY2025 total of 20.5p per share represents a 2% increase on the prior year and confirms management’s commitment to the payout even in a mixed earnings environment (Investing.com).

Upcoming dividend amount

Based on the FY2025 payout of 20.5p, a rough FY2026 estimate would assume a continuation of the H2:H1 split pattern — roughly 13.5p in the final dividend and 7.0p in the interim. At the current share price of 300.6p, that implies a forward yield in the 6.5–7% range, which remains among the most generous on the London market. The dividend has now been raised in three consecutive years, a track record that income-focused investors can point to as evidence of management confidence in cash generation.

Yield calculation

The yield story is real but complicated by measurement timing. Hargreaves Lansdown reports a dividend yield of 6.81% (Hargreaves Lansdown), while Stock Analysis cites figures between 6.94% and 7.92% depending on the methodology used (Stock Analysis). The variation stems from whether analysts use TTM actuals, declared forward dividends, or analyst consensus estimates. The Simply Wall St range of 7.05% to 7.78% is a reasonable benchmark for forward-looking planning. For context: the FTSE 100 average yield sits around 3.5–4%, making M&G roughly double the market average.

Payment schedule

M&G follows a clear pattern: final dividend ex-date typically falls in late March, with payment in early May; interim ex-date is usually mid-September, with October payment. The most recent completed cycle was final ex-date 27 March 2025 (13.50p paid 9 May 2025) and interim ex-date 11 September 2025 (6.70p paid 17 October 2025) (Investing.com Dividends). Investors buying for the dividend should mark these dates: buying before the ex-date is the only way to receive the upcoming payment. For those interested in tracking its performance, the Capitaland Ascendas REIT share price is readily available.

What is the long-term outlook for M&G?

M&G’s transformation programme is past its most painful phase but has not yet reached the finish line. The company’s stated goal of reaching a cost-to-income ratio of 70% by 2027 — from 75% today — is a legitimate target, but it requires continued discipline in cost savings that have already exceeded the £250m milestone (Investing.com). Reaching 70% from 75% sounds incremental, but in a business where margins are thin, even that shift meaningfully improves the operating leverage story.

Growth prospects

The private markets franchise is the growth engine that most differentiates M&G from pure UK life insurers. With £81bn in AUMA and £3.9bn in private markets inflows during FY2025 (Investing.com), this segment commands higher fees and longer-duration relationships than retail-oriented public equity mandates. Fee-related earnings in asset management grew 12% year-on-year (M&G plc FY2025 Results), which is the kind of growth metric that, if sustained, could re-rate the business. International AUMA of £107bn representing 59% of external AUMA with an 11.5% CAGR demonstrates genuine geographical diversification rather than token overseas exposure.

FY results impact

The FY2025 results presentation on 12 March 2026 delivered solid operational numbers wrapped in investor caution. Adjusted operating profit of £838m was stable year-on-year, net inflows of £7.8bn beat expectations, and the Solvency II ratio of 242% provides a substantial capital buffer above regulatory minimums. Yet the share price response was negative: 300.6p represents a 2.63% decline on the day, which suggests the market was looking for either stronger profit beats or clearer signals on how the transformation translates into shareholder returns. The after-tax profit swing to £314m from a £347m loss is the kind of fundamental improvement that should matter to long-term holders — but the market’s short-term focus on near-term earnings quality kept the lid on the share price.

Market position

M&G is not trying to compete globally as a pure asset manager — it is pursuing a differentiated model that blends UK life insurance with asset management, including alternative assets. The 90% of public equities AUM sitting in the top two quartiles over five years (Investing.com) is a meaningful performance credential, though investors should note that past quartile rankings do not guarantee future positioning. The strategy of building fee-related earnings from capital-light sources — which now represent 73% of adjusted operating profit — is the right structural direction for a business trying to escape the earnings volatility of its legacy life insurance book.

The pattern: investors should monitor whether the shift toward fee-related earnings can consistently offset the legacy life insurance volatility in future reporting periods.

How is M&G doing?

By the numbers, M&G is doing better than its share price suggests. Asset management inflows are strong, the capital position is robust, and the dividend is growing — but the market continues to apply a persistent discount that reflects both the complexity of the life insurance balance sheet and the uncertainty about how quickly the transformation will translate into sustained earnings growth.

Recent performance

Year-to-date, MNG.L has gained roughly 6.7% as of early 2026, which puts it slightly ahead of the FTSE Financials sector on a total return basis but still well below the broader FTSE 100 recovery. The 52-week range of £1.96 to £3.25 means the current price of 300.6p is trading nearer the bottom of that range than the midpoint — a function of the persistent uncertainty around life insurer earnings quality rather than any catastrophic operational failure.

Share price news

The most significant recent catalyst was the FY2025 results presentation, where M&G reported £7.8bn in net inflows and a closing AUMA of £376bn — figures that, in any other sector, would typically send a share price sharply higher. The muted response reflects a market that has seen strong operational results from M&G before and been disappointed by below-the-line charges that ate into the reported profit. Until M&G can consistently deliver a positive net profit margin alongside strong inflows, the market will likely continue to treat the shares with caution regardless of the headline numbers.

Why the price is falling

The most honest answer is that M&G’s share price weakness is a valuation story, not an operational crisis. The market is pricing in uncertainty about the life insurance arm that will not be resolved until either the business mix shifts decisively toward asset management revenues, or the life business demonstrates that reserve releases and annuity performance can consistently contribute positively to the bottom line. Gross margins of 52.80% and operating margins of 18.86% look healthy for an insurer, but a profit margin of -0.87% shows how much below-the-line items can erode an otherwise solid operational performance.

The pattern: M&G is operationally stronger than its valuation implies, but the market’s discount reflects legitimate concerns about earnings quality that will not disappear until the net profit margin turns sustainably positive. Income investors are compensated generously for holding through the uncertainty; growth-focused investors may find better opportunities elsewhere on the FTSE.

Related reading: Adidas Adios Pro 3 Review: Specs, Price & Pro 4 Comparison

Frequently asked questions